This article provides an updated review of adjunctive antithrombotic therapy for patients undergoing primary angioplasty for STEMI.
Updated review informs current antithrombotic choices in primary PCI for STEMI; leaves open optimal strategies for future research.
Even though primary angioplasty for STEMI has significantly improved survival when compared with thrombolysis, there is still room for improvement. In fact, despite restoration of optimal epicardial flow in the vast majority of patients, suboptimal myocardial reperfusion is observed in a relatively large proportion of them. The aim of this article is to provide an update review of adjunctive antithrombotic therapy to primary angioplasty for STEMI.
No takes yet. Share an insight, caveat, or question.
Giuseppe De Luca (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: